𝔖 Bobbio Scriptorium
✦   LIBER   ✦

A case of parkinson's disease with L-dopa-evoked catalepsy

✍ Scribed by Hirohide Asai; Fukashi Udaka; Naoya Oishi; Masaya Oda; Hideaki Matsui; Tamotsu Kubori; Kazuto Nishinaka; Yoshiko Furiya; Satoshi Ueno; Masakuni Kameyama

Book ID
116820214
Publisher
Elsevier Science
Year
2006
Tongue
English
Weight
59 KB
Volume
12
Category
Article
ISSN
1353-8020

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

EFFECTS OF L-DOPA IN PARKINSON'S DISEASE
EFFECTS OF L-DOPA IN PARKINSON'S DISEASE
✍ Godwin-Austen, R.B; Frears, C.C; Tomlinson, E.B; Kok, H.W.L πŸ“‚ Article πŸ“… 1969 πŸ› The Lancet 🌐 English βš– 570 KB
Dementia and treatment with L-dopa in Pa
Dementia and treatment with L-dopa in Parkinson's disease
✍ M. Hietanen; Dr. H. TerΓ€vΓ€inen πŸ“‚ Article πŸ“… 1988 πŸ› John Wiley and Sons 🌐 English βš– 536 KB

We compared the neuropsychological performance of patients with Parkinson's disease who were young at onset of the disease (mean age, 41.4 years) and had received prolonged L-dopa treatment (mean, 52.1 months) with nontreated patients of the same age. A similar comparison was made for patients who w

Focusing effects of L-dopa in Parkinson'
Focusing effects of L-dopa in Parkinson's disease
✍ Bernard Ng; Samantha Palmer; Rafeef Abugharbieh; Martin J. McKeown πŸ“‚ Article πŸ“… 2009 πŸ› John Wiley and Sons 🌐 English βš– 397 KB

## Abstract Previous fMRI motor studies in Parkinson's disease (PD) have suggested that L‐dopa may β€œnormalize” areas of hypo‐ and hyperactivity. However, results from these studies, which were largely based on analyzing BOLD signal amplitude, have been conflicting. Examining only amplitude changes